You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR BENDROFLUMETHIAZIDE; NADOLOL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BENDROFLUMETHIAZIDE; NADOLOL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00647660 ↗ Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg Completed Mylan Pharmaceuticals Phase 1 2006-07-01 The objective of this study was to investigate the bioequivalence of Mylan's nadolol/bendroflumethiazide 80 mg/5 mg tablets to King's Corzide® 80 mg/5 mg tablets following a single, oral 80 mg/5 mg (1 x 80 mg/5 mg) dose administered under fasting conditions.
NCT00648297 ↗ Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg Completed Mylan Pharmaceuticals Phase 1 2006-08-01 The objective of this study was to investigate the bioequivalence of Mylan's nadolol/bendroflumethiazide 80 mg/5 mg tablets to King's Corzide® 80 mg/5 mg tablets following a single, oral 80 mg/5 mg (1 x 80 mg/5 mg) dose administered under fed conditions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BENDROFLUMETHIAZIDE; NADOLOL

Condition Name

Condition Name for BENDROFLUMETHIAZIDE; NADOLOL
Intervention Trials
Healthy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BENDROFLUMETHIAZIDE; NADOLOL
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BENDROFLUMETHIAZIDE; NADOLOL

Trials by Country

Trials by Country for BENDROFLUMETHIAZIDE; NADOLOL
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BENDROFLUMETHIAZIDE; NADOLOL
Location Trials
North Dakota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BENDROFLUMETHIAZIDE; NADOLOL

Clinical Trial Phase

Clinical Trial Phase for BENDROFLUMETHIAZIDE; NADOLOL
Clinical Trial Phase Trials
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BENDROFLUMETHIAZIDE; NADOLOL
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BENDROFLUMETHIAZIDE; NADOLOL

Sponsor Name

Sponsor Name for BENDROFLUMETHIAZIDE; NADOLOL
Sponsor Trials
Mylan Pharmaceuticals 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BENDROFLUMETHIAZIDE; NADOLOL
Sponsor Trials
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.